Histopathological changes in pre-treated group, treated group and normal diet group. by Yasmin Mohd Zainal Abidin Shukri (20558861)

Subjects:

Fig 3 - by Yasmin Mohd Zainal Abidin Shukri (20558861)

Subjects:

Experimental outline for saffron extraction and HPLC analysis. by Yasmin Mohd Zainal Abidin Shukri (20558861)

Subjects:

Animal experimental protocol: Rabbit grouping. by Yasmin Mohd Zainal Abidin Shukri (20558861)

Subjects:

Fig 4 - by Yasmin Mohd Zainal Abidin Shukri (20558861)

Subjects:

HPLC data. by Yasmin Mohd Zainal Abidin Shukri (20558861)

Subjects:

Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

Subjects:

Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

Subjects:

Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

Subjects:

iPLA₂γ KO mice show increased glomerular autophagy. by Andrey V. Cybulsky (4007012)

Subjects:

Analyze data. by Xinhui Zhang (1624039)

Subjects:

Mouse spinal cord injury strike parame. by Xinhui Zhang (1624039)

Subjects:

NeuN expression and neuronal apoptosis in Sham and severely injured groups. by Xinhui Zhang (1624039)

Subjects:

Constructing the T10 spinal cord injury model. by Xinhui Zhang (1624039)

Subjects:

Expression of NeuN and CIRBP proteins in Sham and severely injured groups. by Xinhui Zhang (1624039)

Subjects:

Expression of IBA1 and CIRBP proteins in Sham and severely injured groups. by Xinhui Zhang (1624039)

Subjects:

Log2 fold change (FC) of the overlaps of lipid metabolites between the study groups and those significant metabolites that appear exclusively in a single group (unique) represented... by Laia Bertran (3685147)